Yang Rick
Insider CIK 1851328 · SVRA 10% owner · BHG Director, 10% owner · KRRO 10% owner · MBX 10% owner · SGP 10% owner · GLUE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRRO Korro Bio, Inc. | P Buy deriv | 2026-03-10 | 2026-03-12 | 242,945 | $11.11 | $2.70M | 242,945 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-03-10 | 2026-03-12 | 207,100 | $11.11 | $2.30M | 1,297,893 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 937,500 | $16.00 | $15.00M | 6,035,038 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 5,097,538 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 4,359,576 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 2,989,408 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 1,619,240 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 186,128 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 125,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 124,085 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 607,536 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 1,656,789 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 37,700 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 75,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 2,455 | $6.75 | $16.6K | 1,654,334 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 488,702 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 186,128 | $0.01 | $1.9K | 674,830 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 276 | $6.75 | $1.9K | 674,554 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 674,554 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 1,656,789 | $0.01 | $16.6K | 1,656,789 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 488,982 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 607,536 | $0.01 | $6.1K | 2,261,870 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 900 | $6.75 | $6.1K | 2,260,970 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 124,085 | $0.01 | $1.2K | 2,385,055 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 182 | $6.75 | $1.2K | 2,384,873 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 2,384,873 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 185,595 | — | $0 | 556,782 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2024-04-22 | 2024-04-24 | 17,857 | $56.00 | $1000.0K | 1,090,793 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 371,187 | — | $0 | 371,187 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-12-19 | 2023-12-21 | 175,525 | — | $0 | 1,656,789 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-10-31 | 2023-11-02 | 100,606 | — | $0 | 1,481,264 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-09-15 | 2023-09-19 | 552,263 | — | $0 | 1,380,658 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-08-11 | 2023-08-16 | 828,395 | — | $0 | 828,395 | SEC↗ |
| SVRA Savara Inc | P Buy | 2023-07-17 | 2023-07-19 | 333,333 | $3.00 | $1000.0K | 24,471,264 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 37,700 | $1000.00 | $37.70M | 37,700 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |